Sandler Capital Management Qiagen N.V. Transaction History

Sandler Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$35.73 - $41.39 $19.9 Million - $23.1 Million	-558,129 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$33.78 - $40.68 $8.31 Million - $10 Million	-245,920 Reduced 30.59%	558,129 $22.7 Million
Q4 2018 Feb 14, 2019	BUY	$32.65 - $37.95 $539,378 - $626,934	16,520 Added 2.1%	804,049 $27.7 Million
Q3 2018 Nov 14, 2018	BUY	$35.99 - $39.39 $1.55 Million - $1.7 Million	43,139 Added 5.8%	787,529 $29.8 Million
Q2 2018 Aug 14, 2018	BUY	$31.23 - $37.47 $12.4 Million - $14.8 Million	396,080 Added 113.71%	744,390 $26.9 Million
Q1 2018 May 15, 2018	BUY	$31.01 - $34.72 $8.22 Million - $9.2 Million	264,970 Added 317.94%	348,310 $11.3 Million
Q4 2017 Feb 14, 2018	SELL	$30.68 - $35.37 $2.96 Million - $3.41 Million	-96,440 Reduced 53.64%	83,340 $2.58 Million
Q3 2017 Nov 14, 2017	BUY	$31.02 - $32.94 $5.58 Million - $5.92 Million	179,780	179,780 $5.66 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.4B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

Stay updated on Sandler Capital Management with notifications on news.